Barclays Adjusts Bristol-Myers Squibb Price Target to $42 From $41, Maintains Underweight Rating
Barclays Adjusts Bristol-Myers Squibb Price Target to $42 From $41, Maintains Underweight Rating
巴克莱银行将施贵宝的目标价格由41美元调整为42美元，维持低于市场表现评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册